- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.73 Å
- Oligo State
- monomer
- Ligands
- 1 x KO5: (2~{S})-8-[[4-[4-(5-fluoranyl-2-methyl-phenyl)butoxy]phenyl]carbonylamino]-4-(4-oxidanyl-4-oxidanylidene-butyl)-2,3-dih ydro-1,4-benzoxazine-2-carboxylic acid(Non-covalent)
- 1 x CLR: CHOLESTEROL(Non-covalent)
- 1 x 1PE: PENTAETHYLENE GLYCOL(Non-functional Binders)
- 13 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)(Non-functional Binders)
OLC.4: 5 residues within 4Å:- Chain A: F.20, E.23, F.24, I.27
- Ligands: OLC.5
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:F.24, A:I.27, A:I.27
OLC.5: 6 residues within 4Å:- Chain A: F.20, F.24, K.368, I.372, L.376
- Ligands: OLC.4
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:I.372, A:L.376
- Hydrogen bonds: A:K.368, A:K.368
OLC.6: 5 residues within 4Å:- Chain A: P.76, D.80, L.83, R.84
- Ligands: OLC.11
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:P.76
- Salt bridges: A:R.84
OLC.7: 3 residues within 4Å:- Chain A: G.39, C.382, F.383
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:F.383
OLC.8: 5 residues within 4Å:- Chain A: F.199, T.200, I.203, C.204
- Ligands: OLA.18
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:F.199, A:I.203
OLC.9: 4 residues within 4Å:- Chain A: F.198, F.199, S.202
- Ligands: OLA.17
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:F.198, A:F.199, A:F.199
OLC.10: 2 residues within 4Å:- Chain A: V.37, Y.45
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:Y.45
OLC.11: 4 residues within 4Å:- Chain A: D.80, R.84
- Ligands: OLC.6, OLA.21
No protein-ligand interaction detected (PLIP)OLC.12: 11 residues within 4Å:- Chain A: L.212, E.216, L.322, H.325, R.326, L.329, T.330, I.333, I.337
- Ligands: OLA.20, OLA.23
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:L.329, A:I.333, A:I.333, A:I.337
- Hydrogen bonds: A:E.216, A:L.322, A:R.326
OLC.13: 3 residues within 4Å:- Chain A: Y.205
- Ligands: OLC.16, OLA.20
No protein-ligand interaction detected (PLIP)OLC.14: 5 residues within 4Å:- Chain A: Y.111, L.149, I.188, V.192
- Ligands: KO5.1
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:Y.111, A:Y.111, A:L.149, A:L.149, A:I.188, A:V.192
OLC.15: 3 residues within 4Å:- Chain A: I.89, F.90, G.91
No protein-ligand interaction detected (PLIP)OLC.16: 1 residues within 4Å:- Ligands: OLC.13
No protein-ligand interaction detected (PLIP)- 7 x OLA: OLEIC ACID(Non-covalent)
OLA.17: 6 residues within 4Å:- Chain A: Y.187, L.190, V.191, L.196, T.351
- Ligands: OLC.9
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:Y.187, A:Y.187, A:L.190, A:V.191, A:T.351
OLA.18: 5 residues within 4Å:- Chain A: Y.121, L.196, F.199, L.207
- Ligands: OLC.8
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:L.196, A:F.199, A:L.207
- Hydrogen bonds: A:Y.121
OLA.19: 1 residues within 4Å:- Chain A: R.210
No protein-ligand interaction detected (PLIP)OLA.20: 7 residues within 4Å:- Chain A: Y.205, L.212, L.213, E.216, L.336
- Ligands: OLC.12, OLC.13
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:Y.205, A:L.336
- Hydrogen bonds: A:E.216
OLA.21: 3 residues within 4Å:- Chain A: L.48, L.69
- Ligands: OLC.11
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:L.69
OLA.22: 9 residues within 4Å:- Chain A: S.67, L.70, F.71, S.101, N.105, W.140, G.144, W.147, M.151
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:L.70, A:N.105, A:W.140, A:W.147
OLA.23: 3 residues within 4Å:- Chain A: T.330, F.390
- Ligands: OLC.12
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:F.390
- Hydrogen bonds: A:T.330
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gusach, A. et al., Structural basis of ligand selectivity and disease mutations in cysteinyl leukotriene receptors. Nat Commun (2019)
- Release Date
- 2019-12-11
- Peptides
- Cysteinyl leukotriene receptor 2,Soluble cytochrome b562,Cysteinyl leukotriene receptor 2: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.73 Å
- Oligo State
- monomer
- Ligands
- 1 x KO5: (2~{S})-8-[[4-[4-(5-fluoranyl-2-methyl-phenyl)butoxy]phenyl]carbonylamino]-4-(4-oxidanyl-4-oxidanylidene-butyl)-2,3-dih ydro-1,4-benzoxazine-2-carboxylic acid(Non-covalent)
- 1 x CLR: CHOLESTEROL(Non-covalent)
- 1 x 1PE: PENTAETHYLENE GLYCOL(Non-functional Binders)
- 13 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)(Non-functional Binders)
- 7 x OLA: OLEIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gusach, A. et al., Structural basis of ligand selectivity and disease mutations in cysteinyl leukotriene receptors. Nat Commun (2019)
- Release Date
- 2019-12-11
- Peptides
- Cysteinyl leukotriene receptor 2,Soluble cytochrome b562,Cysteinyl leukotriene receptor 2: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.